Alpha-1 antitrypsin (α1-AT) plasma levels in lung, prostate and breast cancer patients

Neuroendocrinology Letters

Volumn 29, Issue 4, 2008, Pages 482-484

  El Akawi, Zeyad J ^a   Al Hindawi, Fatin K ^b   Bashir, Nabil A ^a  

^a JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

^b JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

Alpha 1 antitrypsin; Breast; Cancer; Lung; Prostate

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; IMMUNODIFFUSION; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROTEIN BLOOD LEVEL;

EID: 54349093030     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Carrell WR, Jeppson J, Laurell C, Brennan OS, Owen CM, Vaughan L, et al. Structure and variation of human alpha-1 antitrypsin. Nature 1982; 298: 329-33.
2. Crystal GR, Brantly LM, Hubbard CR, Curried TD, States JD, Holmes DM. The alpha-1 antitrypsin gene and its mutations. Chest 1989; 95(1): 196-208.
3. Coakley RJ, Taggart C, O'Neill S, McElvaney NG. Alpha-1 antitrypsin deficiency: biological answers to clinical questions. Am. J. Med. Sci. 2001; 321(1): 33-41.
4. Huber R, Carrell RW. Implications of the three-dimensional structure of alpha-1 antitrypsin for structure and function of serpins. Biochemistry 1989; 28(23): 8951-66.
5. Sparos L, Tountas Y, Chapuis-Cellier C, Theodropoulos G, Trichopoulos D. Alpha-1 antitrypsin levels and phenotypes and hepatitis B Serology in liver cancer. Br. J. Cancer 1984; 49: 567-70.
6. Debrowska M, Mantur M, Panasiuk A, Prokopowicsz J. Does the concentration of alpha-1 proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma? Neoplasma 1997; 44(5): 305-7.
7. Ananhtakrishnan R, Biegler B, Dennis PM. Alpha-1 antitrypsin phenotypes in paraproteinemias, The Lancet 1979; 10: 561-2.
8. Pellinieme TT, Irjala K, Mattila K, Pulkki K, Tienhaara A, Laakso M, et al. for the Finnish Leukemia Group, Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Blood 1995; 85(3): 765-71.
9. Tountas Y, Sparos L, Theodoropoulous C, Trichopoulos D. Alpha-1 antitrypsin and cancer of the pancreas. Digestion 1985; 31(1): 37-40.
10. Zietek Z, Iwan-Zietek I, Kotschy M, Tyloch F, Activity of alpha-1 antitrypsin in blood of patients with prostatic tumor. Pol. Tyg. Lek 1996; 51(6-9): 89-90.
11. Ward AM, Cooper EH, Houghton AL. Acute-phase reactant proteins in prostatic cancer. British Journal of Urology 1977; 49: 411-18.
12. Bata J, Colobert L, Biron A, Brune J, Study of various serum proteins in lung cancer. Immunoglobulins A, G, M, haptoglobin, alpha-1 antitrypsin, alpha-2 macroglobin. Annales de Biologie Clinique 1977; 35(4): 297-303.
13. Daddi G, Mancini PA, Parola D, Contini A. Alpha-1 antitrypsin increase in lung cancer. Bollettino dell'Istituto Sieroteropico milanese 1976; 55(6): 510-2.
14. Apicella C, Carniato A, Ippoliti F, Romano V, Tomai A, Ferrari S. Relations between serum alpha-1 antitrypsin level and neoplasms. Archivio Per le Scienze Mediche 1976; 133(2): 103-8.
15. Harris CC, Cohen MH, Conner R, Primack A, Saccomanno G, Talamo RC. Serum alpha-1 antitrypsin in patients with lung cancer or abnormal sputum cytology. Cancer 1976; 38(4): 1655-7.
16. Hirmatsu S, Kojima J, Okada TT, Ohmori IK. The serum protein profile in chronic hepatitis, cirrhosis and liver cancer. Acta hepato-gastroenterologica 1976; 23(3): 177-82.
17. Ward AM, Cooper EH, Turner R, Anderson JA, Neville AM. Acute-phase reactant profiles: an aid to monitoring large bowel cancer by CEA and serum enzymes, British Journal of Cancer 1977; 35(2): 170-8.
18. Latner AL, Turner GA, Lamin MM. Plasma alpha-1 antitrypsin levels in early and late carcinoma of the cervix. Oncology 1976; 33(1): 12-4.
19. Patenoster D, Cartei G, Campagnutta E, Maggino T, Valente S, Ongaro G. Acute reactive stage proteins in gynaecologic cancers. Eur. J. Gynaecol. Oncol. 1980; 1(2): 94-8.
20. Dumitrascu D, Radu D, Stanciul L, Ionita A, Petcovici M. Alpha-1 antitrypsin, alpha 2-macroglobulin and reactive protein C in gastric cancer. Rev. Med. Interna. Neurol. Psihiatr. Neurochir. Dermatoveneral Med. Interna. 1989; 41(1): 57-61.
21. Krecicki T, Leluk M. Acute phase reactant proteins: an aid to monitoring surgical treatment of laryngeal carcinoma. J. Laryngol. Otal. 1992; 106(7): 613-5.
22. Mattison P, Cove DH, Walsh L, Howell A, Mc Conkey B, Morrison JM. Serum proteins as tumor markers for breast cancer. Br. J. Cancer 1981; 43: 542-5.
23. Amiguet JA, Jimenez J, Monreal JI, Hernandez MJ, Lopez-Vivanco G, Vidan JR, et al. Serum proteolytic activities and antiproteases in human colorectal carcinoma. J. Physiol. Biochem. 1998; 54(1): 9-13.
24. Chio LF, Oon C. Changes in serum alpha-1antitrypsin, alpha-1 acid glycoprotein and beta-2 glycoprotein 1 in patients with malignant hepatocellular carcinoma. Cancer 1979; 43: 596-604.
25. Beimond I, Goedhard JG, Klasen EC, Vanden Boomgaard DM, Kreuning J, Pe'a AS, et al. Alpha-1 antitrypsin phenotypes and serum concentrations in duodenal ulcer patients in the Netherlands. Digestion 1988; 39(1): 20-5.
26. Wakefield D, Easter J, Breit SN, Clark P, Penny R. Alpha-1 antitrypsin serum levels and phenotypes in patients with retinal vasculitis. Br. J. Ophthalmol. 1985; 69(7): 497-9.
27. Klasen EC, Biemond I, Weterman IT. Alpha-1 antitrypsin levels and phenotypes in Crohn's disease in the Netherlands. Gut 1980; 21(10): 840-2.
28. Huang H, Campbell SC, Nelius T, Bedford DF, Veliceasa D, Bouck NP, et al. Alpha-1-antitrypsin inhibits angiogenesis and tumor growth. Int. J. Cancer 2004; 112(6): 1042-8.
29. Micksche M, Kokron O. Serum levels of alpha-1 antitrypsin and alpha-2 macroglobulin in lung cancer. Das osterreichische Kneipp-Magazin 1977; 3(5-6): 116-9.
30. Kuvibidila S, Rayford W. Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer. J. Lab. Clin. Med. 2006; 147 (4): 174-81.
31. Demidove VP, Iakubovskaia RI, Karmakova TA, Avdeev GI., Komissarov AB, Sorokin EE, et al. Alpha-1 proteinase inhibitor in breast cancer. Vopr. Onkol. 1990; 36(1): 23-9.
32. Thompson DK, Haddow JE, Smith DE, Ritchie RF. Elevated serum acute phase protein levels as predictors of disseminated breast. Cancer 1983; 51(11): 2100-4.
33. Doustjalali SR, Yusof A, Yib CH, Looi LM, Pillay B, Hashim OH. Abberent expression of acute-phase reactant proteins in sera and breast lesions of patients with malignant and benign breast tumors. Electrophoresis 2004; 25(14): 2392-401.